International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 5
September-October 2024
Indexing Partners
Review On Omicron Variant (B.1.1.529) of SARS-CoV2
Author(s) | S.U.Salma, P. Akhila, P. Ruchitha, S. Pushpa sree, Dr. V. Jaya Sankar Reddy, Dr. K.T.Naik |
---|---|
Country | India |
Abstract | The virus that causes COVID-19 is called SARS-CoV-2, and it has an Omicron variant. It is the most recent COVID-19 version. This variety, known as omicron, was initially reported to the WHO on November 24, 2021, from South Africa. The WHO's Technical Advisory Group on Virus Evolution (TAG-VE) identified PANGO lineage B.1.1.529. with the Greek letter omicron and declared it a variety of concern on November 261. Omicron possesses multiple mutations that could affect its behaviour, including the degree of disease severity and its transmissibility1. Omicron is thought to be more contagious than its predecessors, spreading around 70 times as quickly18. The omicron variety is found in numerous nations worldwide2. Omicron will therefore not be a final variant, but it may be the final Variant Of Concern (VOC) 8. Numerous spike protein mutations linked to enhanced infectivity and antibody evasion are also present in other variations of concern. According to computational modelling, the variation might also be able to evade cell-mediated immunity23. By sufficiently changing its chemical structure to avoid identification by the immune system, SARS-CoV-2 can evade the immune system8. |
Keywords | Omicron, SARS-CoV-2, Mutations, Variants |
Field | Biology > Medical / Physiology |
Published In | Volume 6, Issue 2, March-April 2024 |
Published On | 2024-04-30 |
Cite This | Review On Omicron Variant (B.1.1.529) of SARS-CoV2 - S.U.Salma, P. Akhila, P. Ruchitha, S. Pushpa sree, Dr. V. Jaya Sankar Reddy, Dr. K.T.Naik - IJFMR Volume 6, Issue 2, March-April 2024. DOI 10.36948/ijfmr.2024.v06i02.18837 |
DOI | https://doi.org/10.36948/ijfmr.2024.v06i02.18837 |
Short DOI | https://doi.org/gts4sj |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.